Evalueserve

DECEMBER 6, 2021

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. These companies will be able to reshape the competitive landscape of the pharmaceutical industry.

Capital 98

Capital Globalization Biotech Marketing 98

CIO

DECEMBER 27, 2023

These countries offer competitive salaries, a lower cost of living compared to other major tech hubs, and better opportunities for quality of life and work-life balance. It’s also home to Canada’s largest tech park, called Kanata North Technology Park, home to more than 540 companies and 23,000 employees. in the San Francisco Bay Area.

Startups 860

Startups Biotech Capital Innovation 860

Alpha Sense BI

APRIL 19, 2024

Over the past few years, the technology industry has experienced dramatic highs and lows. Below, we dive into the key trends that will shape the technology landscape in upcoming quarters and share the key insights that will keep you ahead of the market. As we navigate 2024, the landscape appears positioned for a triumphant comeback.

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

APRIL 29, 2024

Market Analysis : A valuable tool for conducting market research , as it can analyze large volumes of market data, predict market trends, analyze customer preferences, and provide a snapshot of the competitive landscape. Competition for fundraising will continue heating up among startup companies in 2024.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

MAY 28, 2024

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.

Capital 69

Capital Startups Biotech Due Diligence 69

Alpha Sense BI

JUNE 6, 2024

In today’s fast-paced and ever-evolving business landscape, staying ahead of the competition is more challenging yet more crucial than ever. Having a dedicated and comprehensive competitor analysis framework is critical, as is the ability to access all the competitive information you need in one place.

Competitor Analysis 40

Competitor Analysis Analysis Battlecard SWOT 40

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital. The post Key Takeaways from J.P.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

SEPTEMBER 1, 2023

The IRA’s impact on drug negotiations and financial exposure could also change the balance of technologies and disease states that are funded in the future. Below are the quintessential MI resources for staying ahead of the competition in today’s market. Drug Prices Up for Negotiation The U.S.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

APRIL 12, 2024

Generally, expert calls provide investment researchers with the operator’s perspective, which is critical to understanding competitive moats and enhancing data-driven research with soft data. For example, how do you learn why a major cloud platform lags behind its peers, whether it’s driven by technology or marketplace dynamics?

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Engage3

MAY 19, 2022

Ken Ouimet, PhD Founder/Chairman, Technology Committee Ken Ouimet is the Chair of Strategic Planning and Founder of Engage3 and is credited with creating the retail revenue management and price optimization market. His first company, Khimetrics, led the industry for almost a decade before being successfully acquired by SAP in 2006.

Retail 52

Retail Capital Finance Biotech 52

CIO

JULY 17, 2023

Many IT leaders today are focused more on security management as well as improving IT operations and systems performance than they are on top-line and strategic activities such as driving business innovation, identifying competitive differentiation opportunities, and even working on business strategy.

Biotech 617

Biotech Innovation Technology Technology 617

Alpha Sense BI

NOVEMBER 9, 2022

Management announced the sale of a 55% stake of the HVAC-focused Climate Technologies business to Blackstone, valuing the entity at $14 billion. Emerson ultimately plans to divest all of Climate Technologies but this initial sale accelerates Emerson’s strategic pivot to an automation pure-play. Rumsey, President, CEO & Director.

Sales 52

Sales Loss Capital Biotech 52

Alpha Sense BI

MARCH 13, 2024

billion acquisition of Carmot Therapeutics, a clinical-stage biotechnology company with three GLP-1 assets in clinical production, including its CT-388 lead GLP-1 asset, in the hopes of gaining a competitive footing among Novo Nordisk and Eli Lilly’s products currently on the market (Ozempic, Wegovy, and Mounjaro, respectively).

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

Our platform uses proprietary and market-leading AI technology that integrates machine learning and NLP to help users extract the information they need in seconds from thousands of previously disparate business data sources. Stream by Alphasense also prioritizes compliance throughout the content development process.

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52

Happy Market

MAY 9, 2022

Let’s ask everything we can possibly imagine, and then let technology tell us what matters, and it’s really landed well with the companies who subscribe to our platform. [00:20:00]. John Dick: Right. [00:36:04].

Management 52

Management Entertainment Market Research Marketing Research 52